Bioluminescence Imaging-Based Assessment of the Anti-Triple-Negative Breast Cancer and NF-Kappa B Pathway Inhibition Activity of Britanin
Open Access
- 5 May 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 575
- https://doi.org/10.3389/fphar.2020.00575
Abstract
Britanin has been reported to have therapeutic effects on neurodegenerative and inflammation-based diseases. However, whether it is involved in the regulation of triple-negative breast cancer development has not been elucidated. In this study, we investigated the anti-tumor activity against triple-negative breast cancer tumor of Britanin by bioluminescence imaging in vivo using athymic (nu/nu) mice implanted with MDA-MB-231 and SUM-159 cells expressing a luciferase reporter gene, and explored the anti-tumor mechanism of Britanin. The results showed that Britanin treatment inhibited triple-negative breast cancer cell proliferation in vivo, and Cell Counting Kit-8 (IC50 values are 4.27 and 5.05 μM) and colony formation tests (P < 0.001) confirmed this result. Transwell assays were conducted to verify that Britanin treatment inhibited cell migration and invasion (P < 0.001). Apoptosis was determined by TdT-mediated dUTP nick-end labeling method. Western blot and qRT-PCR analysis showed that Britanin treatment caused a decrease in the member expression of NF-kappa B signaling pathway. Computational modeling showed that Britanin could directly bind to a p-65 core region composed of Cys38, Cys120, and Gln128 residues. The results showed that the inhibitory mechanisms of Britanin on cancer cells may be by ways of inhibiting the NF-kappa B pathway. In addition, bioluminescence imaging screening system is useful for accelerating the application of Britanin in the antitumor field, and provides a useful tool for evaluating the phytochemicals efficacy in inhibiting cancer cell proliferation in animal models.Keywords
This publication has 20 references indexed in Scilit:
- Toward precision medicine of breast cancerTheoretical Biology and Medical Modelling, 2016
- Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast CancerCancer Research, 2014
- Suppressive Effects of Britanin, a Sesquiterpene Compound Isolated from Inulae Flos, on Mast Cell-Mediated Inflammatory ResponsesThe American Journal of Chinese Medicine, 2014
- Combination versus sequential single agent chemotherapy for metastatic breast cancerEmergencias, 2013
- Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the processEuropean Journal of Nutrition, 2010
- Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS)Breast Cancer Research and Treatment, 2008
- Role of dietary lignans in the reduction of breast cancer riskMolecular Nutrition & Food Research, 2007
- Molecular imaging in drug discovery and developmentNature Reviews Drug Discovery, 2003
- New insights into intracellular lipid binding proteins: The role of buried waterProtein Science, 2002
- The Crystal Structure of the IκBα/NF-κB Complex Reveals Mechanisms of NF-κB InactivationCell, 1998